Jonathan Mow
Chief Executive Officer at PhaseBio Pharmaceuticals
Find your path to Jonathan
3 people in our graph share verified history with Jonathan — schools, employers, funds. One of them is your warm intro.
Clay ThorpunlockedJonathan: together at PhaseBio Pharmaceuticals
×2Jonathan: together at PhaseBio Pharmaceuticals
About
Mow joined PhaseBio as Chief Business Officer in 2012 and led the company as CEO from 2015 to 2023, later serving as Chief Executive Officer of VERALOX Therapeutics. His earlier career included VP of Business Development at Amylin Pharmaceuticals, co-founding Corus Pharma, where he was VP of Commercial and Business Development, and roles at PathoGenesis, Bristol Myers Squibb, and Lederle International.
Chief Executive Officer at PhaseBio Pharmaceuticals
Intro paths
→
In turn, Jonathan can intro founders to PhaseBio Pharmaceuticals's investors below.
PhaseBio Pharmaceuticals's investors · 5
Co-founders at PhaseBio Pharmaceuticals
AC
Ashutosh ChilkotiDirector
Frequently asked questions
- Who is Jonathan Mow?
- Mow joined PhaseBio as Chief Business Officer in 2012 and led the company as CEO from 2015 to 2023, later serving as Chief Executive Officer of VERALOX Therapeutics. His earlier career included VP of Business Development at Amylin Pharmaceuticals, co-founding Corus Pharma, where he was VP of Commercial and Business Development, and roles at PathoGenesis, Bristol Myers Squibb, and Lederle International.
- Where does Jonathan Mow work?
- Jonathan Mow is Chief Executive Officer at PhaseBio Pharmaceuticals.